AADvac1 is a candidate therapeutic vaccine for Alzheimer's disease that targets misfolded tau protein, a common denominator of neurofibrillary pathologyRead more...
ACAM2000 Smallpox Vaccine
ACAM2000 is a live vaccinia virus to protect against smallpox disease.Read more...
Ad26.Mos4.HIV HIV Vaccine
Ad26.Mos4.HIV is a tetravalent vaccine candidate containing recombinant adenovirus serotype 26 (Ad26) vectors with mosaic inserts.Read more...
Ad26.ZEBOV/MVA-BN-Filo Ebola Vaccine
Ad26.ZEBOV/MVA-BN-Filo is a heterologous prime-boost Ebola vaccine regimen.Read more...
Ad5-GUCY2C-PADRE Colon Cancer Vaccine
Ad5-GUCY2C-PADRE is a replication-deficient human type 5 recombinant adenovirus (Ad5) vaccine encoding guanylyl cyclase C (GUCY2C) fused to the PAn DR Epitope (PADRE). GUCY2C, a paracrine hormone receptor producing the second messenger cyclic GMP (cGMP), is selectively expressed by intestinal epithelial cells and a subset of hypothalamic neurons, but not other tissues. Read more...
Adacel Diphtheria Vaccine
Adacel vaccine contains noninfectious tetanus, diphtheria, and pertussis proteins, aluminum phosphate, 2-phenoxyethanol, and residual amounts of formaldehyde and glutaraldehyde. Adacel vaccine does not contain preservatives.Read more...
Adacel Pertussis Vaccine
Adacel vaccine contains noninfectious tetanus, diphtheria, and pertussis proteins, aluminum phosphate, 2-phenoxyethanol, and residual amounts of formaldehyde and glutaraldehyde. Adacel vaccine does not contain preservatives.Read more...
Adacel Tetanus Vaccine
Adacel vaccine contains noninfectious tetanus, diphtheria, and pertussis proteins, aluminum phosphate, 2-phenoxyethanol, and residual amounts of formaldehyde and glutaraldehyde. Adacel vaccine does not contain preservatives.Read more...
Afluria Influenza Vaccine
Afluria is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B present in the vaccine.Read more...
AGI-134 Cancer Immunotherapy Vaccine
AGI-134 is a synthetic molecule that by intratumoral injection triggers a systemic anti-tumor response.Read more...
ASP3772 Pneumococcal Vaccine
ASP3772 utilizes the Multiple Antigen Presenting System (MAPS) platform which is Affinivax’s proprietary, next-generation vaccine technology. MAPS uniquely presents key epitopes of the desired antigens (polysaccharides and/or proteins) to induce a robust and broad immune response against challenging diseases.Read more...
ATX-GD-59 Graves' Disease Vaccine
ATX-GD-59 is a candidate for potential treatment to target the immunological basis of Graves' disease.Read more...
AV7909 Anthrax Vaccine
AV7909 is a combination of BioThrax (also called anthrax vaccine, adsorbed or AVA), an FDA-licensed vaccine, and CPG 7909.Read more...
Bacille Calmette-Guerin Tuberculosis Vaccine
Bacille Calmette-Guerin (BCG) is an attenuated, live culture preparation of the Bacillus of Calmette and Guerin (BCG) strain of Mycobacterium bovis. The TICE® strain used in this BCG vaccine preparation was developed at the University of Illinois from a strain originated at the Pasteur Institute.Read more...
Bexsero Meningitis B Vaccine
Bexsero contains different proteins taken from group B Neisseria meningitidis bacteria. The combination of proteins was chosen to protect against the majority of MenB strains. They are also expected to protect against other types of meningococcal bacteria, including MenW.Read more...
BG505 SOSIP.664 gp140 HIV Vaccine
BG505 SOSIP.664 gp140 is a stable, soluble, cleaved HIV envelope trimer. Read more...
BioThrax Anthrax Vaccine
BioThrax, Anthrax Vaccine Adsorbed, is made from cell-free filtrates of microaerophilic cultures of an avirulent, nonencapsulated strain of Bacillus anthracis.Read more...
Boostrix Diphtheria Vaccine
Boostrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria and purified proteins of pertussis bacteria. The inactive ingredients in the vaccine are aluminium hydroxide, aluminium phosphate, formaldehyde, polysorbate 80, sodium chloride (salt), glycine and water.Read more...
Boostrix Pertussis Vaccine
Boostrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria and purified proteins of pertussis bacteria. The inactive ingredients in the vaccine are aluminium hydroxide, aluminium phosphate, formaldehyde, polysorbate 80, sodium chloride (salt), glycine and water.Read more...
Boostrix Tetanus Vaccine
Boostrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria and purified proteins of pertussis bacteria.Read more...
BPZE1 Pertusiss Vaccine
BPZE1 is an intranasal vaccine candidate that consists of a live, attenuated form of the pertussis bacterium.Read more...
Cervarix HPV Cancer Vaccine
Cervarix is a non-infectious recombinant, AS04-adjuvanted vaccine, that contains recombinant L1 protein, the major antigenic protein of the capsid, of oncogenic HPV types 16 and 18. Read more...
ChAdOx1 MERS MERS-CoV Vaccine
ChAdOx1 MERS is a vaccine candidate to treat MERS-CoV. Read more...
CHIKV-VLP Chikungunya Vaccine
Chikungunya Virus virus-like particle (CHIKV-VLP) vaccines are multi-protein structures that mimic the organization and conformation of naturally occurring viruses, without the viral genome, that could potentially promote a stronger immune response and increased antibody production.Read more...
Chirorab Rabies Vaccine
Chirorab is an inactivated rabies virus of the strain Flury LEP.Read more...
Coronavirus Vaccines
Coronavirus Viruses
Human coronaviruses were first identified in the mid-1960s. The best-known Conoaviruses are Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV), and a new one, named 2019 Novel Coronavirus... Read more...
CRV 101 Shingles Vaccine
CRV-101 is a next-generation vaccine designed to maximize the CMI protection by combining the gE protein antigen with our proprietary adjuvantRead more...
CTH522 Chlamydia Vaccine
CTH522 is a Chlamydia vaccine candidate adjuvanted with CAF01 liposomes or aluminium hydroxide.Read more...
CVD 1208S-122 Diarrhea vaccine
CVD 1208S-122 is a diarrhea vaccine candidate comprised of a weakened live strain of Shigella expressing protective antigens from ETEC
Daptacel contains 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, and acellular pertussis antigens [10 µg detoxified pertussis toxin (PT), 5 µg filamentous hemagglutinin (FHA), 3 µg pertactin, and 5 µg fimbriae types 2 and 3 (FIM)] in each 0.5-mL dose.Read more...
Daptacel Diphtheria Vaccine
Daptacel contains 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, and acellular pertussis antigens [10 µg detoxified pertussis toxin (PT), 5 µg filamentous hemagglutinin (FHA), 3 µg pertactin, and 5 µg fimbriae types 2 and 3 (FIM)] in each 0.5-mL dose.Read more...
Daptacel Pertussis Vaccine
Daptacel contains 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, and acellular pertussis antigens [10 µg detoxified pertussis toxin (PT), 5 µg filamentous hemagglutinin (FHA), 3 µg pertactin, and 5 µg fimbriae types 2 and 3 (FIM)] in each 0.5-mL dose.Read more...
Delta gD-2 Herpes Vaccine
Delta gD-2 is a vaccine candidate based on an HSV-2 virus genetically deleted for glycoprotein D (gD-2). Read more...
Dengvaxia Dengue Vaccine
Dengvaxia is a live attenuated tetravalent chimeric vaccine made using recombinant DNA technology by replacing the PrM (pre-membrane) and E (envelope) structural genes of yellow fever attenuated 17D strain vaccine with those from the four dengue serotypes.Read more...
DS-Cav1 RSV Vaccine
DS-Cav1 was developed by VRC, NIAID and is composed of the respiratory syncytial virus (RSV) fusion (F) glycoprotein ectodomain assembled as a trimer stabilized in its prefusion native conformation with a foldon trimerization domain at the C-terminus and 4 internal mutations designated DS-Cav1 (4.1DHFR_RSVAF).Read more...
Ebola Vaccines
Ebola prevention vaccines are given to help protect people from getting Ebola disease.Read more...
Encepur Tick-Borne Encephalitis Vaccine
Encepur is a vaccine that consists of an inactivated and purified Tick-Borne Encephalitis (TBE) virus/strainRead more...
Engerix-B Hepatitis B Vaccine
Engerix-B a Hepatitis B Vaccine is a noninfectious recombinant DNA hepatitis B vaccine.Read more...
Ervebo Ebola Vaccine
Merck's Ervebo V920 (VSV-EBOV) is a recombinant, replication-competent Ebola vaccine, consisting of a vesicular stomatitis virus (VSV), which has been genetically engineered to express a glycoprotein from the Zaire ebolavirus so as to provoke a neutralizing immune response to the Ebola virus.Read more...
EXD-12 Herpes Simplex Vaccine
EXD-12 is a live attenuated herpes simplex vaccine candidate. EXD-12 is going to be tested as a prophylactic and therapeutic vaccine candidate in the guinea pig model. Read more...
Flu-v Influenza Vaccine
FLU-v is a novel peptide vaccine candidate.Read more...
Fluad Influenza Vaccine
Fluad consists of an inactivated, subunit trivalent influenza virus antigen produced in eggs and an oil-in-water emulsion adjuvant, MF59C.1.Read more...
Fluarix Quadrivalent Influenza Vaccine
Fluarix Quadrivalent is prepared from influenza viruses propagated in embryonated chicken eggs. Each of the influenza viruses is produced and purified separately. After harvesting the virus-containing fluids, each influenza virus is concentrated and purified by zonal centrifugation using a linear sucrose density gradient solution containing detergent to disrupt the viruses. Following dilution, the vaccine is further purified by diafiltration.Read more...
Flublok Quadrivalent Influenza Vaccine
Flublok Quadrivalent is a quadrivalent recombinant influenza vaccine. Flublok Quadrivalent consists of the four influenza strains that have been identified to be the most likely strains for the flu seasonRead more...
Flucelvax Quadrivalent Influenza Vaccine
Flucelvax Quadrivalent is a cell culture-based flu vaccine to help offer protection against 4 flu virus strains identified for the current flu season.Read more...
Flulaval Quadrivalent Influenza Vaccine
Flulaval Quadrivalent is a quadrivalent, split-virion, inactivated influenza virus vaccine prepared from virus propagated in the allantoic cavity of embryonated hens’ eggs. Each of the influenza viruses is produced and purified separately. The virus is inactivated with ultraviolet light treatment followed by formaldehyde treatment, purified by centrifugation, and disrupted with sodium deoxycholate.Read more...
FluMist Quadrivalent Influenza Vaccine
FluMist Quadrivalent is an Intranasal vaccine that is a live quadrivalent vaccine that is formulated to contain four vaccine virus strains, for 2018-2019, an A/H1N1 strain, and A/H3N2 strain, and two B strains, the B/Yamagata/16/88 and B/Victoria/2/87 lineages.Read more...
Fluvirin Influenza Vaccine
Fluvirin is a live, attenuated or inactive virus, pathogen or toxoid of the identified flu strains for the particular flu season.Read more...
Fluzone Influenza Vaccine
Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine.Read more...
Fluzone Intradermal Quadrivalent is a vaccine that consists of the 4 influenza strains that have been identified for the current flu season.Read more...
Fluzone Quadrivalent Influenza Vaccine
Fluzone Quadrivalent vaccine contains the 2 strains of influenza A and B identified for the current flu season.Read more...
Gardasil HPV Vaccine
Gardasil consists of 4 proteins of HPV Types 6, 11, 16, and 18, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate, and water.Read more...
Gardasil 9 HPV Vaccine
Gardasil 9 consists of HPV proteins, Types 6, 11, 16, 18, 31, 33, 45, 52, and 58, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, Polysorbate 80, sodium borate, and water for injection.Read more...
GBS6 Group B Streptococcus Vaccine
GBS6 is a multivalent group B streptococcus vaccine candidateRead more...
Gen-003 Genital Herpes (HSV2) Vaccine
GEN-003 is an experimental immunotherapy vaccine comprised of 2 HSV-2 proteins, glycoprotein D2 and ICP4.2, and Matrix-M2 adjuvant (M2).Read more...
GEN-009 Cancer Vaccine
GEN-009 is an investigational, personalized adjuvanted vaccine, that is being developed for the treatment of patients with solid tumors.Read more...
GEO-LM01 Lassa Fever Vaccine
GEO-LM01 is a vaccine candidate that is based on the Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform, which generates noninfectious VLPs in the individual being vaccinatedRead more...
GI.1/GII.4 Norovirus Vaccine
GI.1/GII.4 is a tablet oral norovirus vaccine consisting of both Monovalent GII.4 VXA-G2.4-NS and Monovalent GI.1 VXA-G1.1-NN. Read more...
GLS-5300 MERS-CoV Vaccine
GLS-5300 (INO-4700) is a DNA plasmid vaccine that expresses the MERS CoV spike (S) glycoprotein.Read more...
Havrix Hepatitis A Vaccine
Havrix is a sterile suspension of inactivated virus strain HM175 which is propagated in MRC-5 human diploid cells. After removal of the cell culture medium, the cells are lysed to form a suspension. This suspension is purified through ultrafiltration and gel permeation chromatography procedures. Treatment of this lysate with formalin ensures viral inactivation.Read more...
HBA120 Hepatitis B Vaccine
HBAI20 vaccine candidate consists of a standard HBV vaccine to which the AI20 adjuvant is added.
The adjuvant is able to give an additional stimulus to the immune system and... Read more...
Hecolin Hepatitis E Vaccine
Hecolin is a recombinant vaccine which contains the hepatitis E virus (HEV)-like particles prepared using a recombinant Escherichia coli expression systemRead more...
Heplisav-B Hepatitis B Vaccine
Heplisav-B combines hepatitis B surface antigen with Dynavax's proprietary Toll-like Receptor (TLR), 9 agonist, to enhance the immune response.Read more...
HER-Vaxx Cancer Vaccine
HER-Vaxx (IMU-131) is a B-cell peptide immunotherapy cancer vaccine candidate which is constructed from several B cell epitopes derived from the extracellular domain of HER-2/neu. Read more...
HSV529 Genital Herpes Vaccine
HSV529 is a vaccine candidate that is classified as a replication-defective virus, where the virus possesses all the components of the wild-type HSV virus with the exception of two proteins UL5 and UL29 that are involved in viral DNA replication. This replication-defective HSV2 vaccine can infect cells and should result in a broader immune response.Read more...
HydroVax-001 West Nile Vaccine
HydroVax-001 is a vaccine candidate which consists of a hydrogen peroxide inactivated, whole virion (WNV-Kunjin strain) adjuvanted with aluminum hydroxide.Read more...
ImmuneFx Cancer Therapeutic Vaccine
ImmuneFx is a therapeutic vaccine candidate which expresses a bacterial antigen on the surface of a patient’s own tumor cells. IFx primes and educates the immune system to destroy tumor cells throughout the body without harming healthy cells and tissues.Read more...
Imovax Rabies Vaccine
Imovax Rabies is an inactivated vaccine made from an attenuated rabies virus. It is a sterile, stable, freeze-dried suspension of Rabies Vaccine Inactivated virus prepared from WISTAR Rabies PM/WI 38 1503-3M strain.Read more...
Infanrix Diphtheria Vaccine
Infanrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria, and purified proteins of pertussis bacteria. Each 0.5 mL dose contains: 30 IU (25 Lf U) of diphtheria toxoid.Read more...
Infanrix Pertussis Vaccine
Infanrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria, and purified proteins of pertussis bacteria. Each 0.5 mL dose contains: 30 IU (25 Lf U) of diphtheria toxoid.Read more...
Infanrix Tetanus Vaccine
Infanrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria, and purified proteins of pertussis bacteria. Each 0.5 mL dose contains: 30 IU (25 Lf U) of diphtheria toxoid.Read more...
INO-4500 Lassa Fever Vaccine
INO-4500 is a DNA-encoded monoclonal antibody (dMAb™) immunotherapy vaccine candidate.Read more...
INO-A002 Zika Vaccine
INO-A002 is a DNA-encoded monoclonal antibody (dMAb™) technology candidate.Read more...
IVX-121 Respiratory Syncytial Virus (RSV) Vaccine
IVX-121 an RSV vaccine candidate incorporates a stabilized prefusion F antigen licensed from NIAID/NIHRead more...
Ixiaro Japanese Encephalitis Vaccine
Ixiaro is an inactivated, adsorbed Vero cell culture-derived vaccine. It is prepared by propagating JEV strain SA14-14-2 in Vero cells.Read more...
Japanese Encephalitis Vaccines
Japanese encephalitis virus (JEV) is a flavivirus that is the main cause of viral encephalitis in many countries of Asia with an estimated 68,000 clinical cases every year.Read more...
Jenvac Japanese Encephalitis Vaccine
JENVAC is an inactivated vero cell-derived vaccine prepared from an Indian Kolar strain of the Japanese encephalitis virus.Read more...
Kinrix PolioVirus Vaccine
Kinrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria, and purified proteins of pertussis bacteria as well as Inactivated Poliovirus Vaccine.Read more...
M72/AS01E Tuberculosis Vaccine
M72/AS01E is a subunit vaccine candidate comprised of an immunogenic fusion protein (M72) derived from two Mycobacterium tuberculosis (M.tb) antigens (MTB32A and MTB39A), and the GlaxoSmithKline proprietary adjuvant AS01E.Read more...
mAb114 Ebola Therapeutic Vaccine
mAb114 is a human IgG1 MAb targeted to the Zaire ebolavirus (EBOV) glycoprotein (GP). mAb114 is a single monoclonal antibody which binds to the core receptor binding domain of the Zaire ebolavirus surface protein, preventing the virus from infecting human cellsRead more...
Menactra Meningococcal Vaccine
Menactra contains N meningitidis serogroup 8 A, C, Y and W-135 capsular polysaccharide antigens individually conjugated to diphtheria toxoid 9 protein. N meningitidis A, C, Y, and W-135 strains are cultured on Mueller Hinton agar and 10 grown in Watson Scherp media containing casamino acid.Read more...
Menveo Meningococcal Vaccine
Menveo consists of two portions: 10 µg of lyophilized meningococcal serogroup A capsular polysaccharide conjugated to CRM197 and 5 μg each of capsular polysaccharide of serogroup C, W, and Y conjugated to CRM197 in 0.5 mL of phosphate-buffered saline, which is used to reconstitute the lyophilized MenA component.Read more...
MMR II Measles Vaccine
M-M-R II is also known as Measles, Mumps, and Rubella Virus Vaccine Live, is a live virus vaccine, containing weakened forms of measles virus, mumps virus, and rubella virus.Read more...
MMR II Mumps Vaccine
M-M-R II is also known as Measles, Mumps, and Rubella Virus Vaccine Live, is a live virus vaccine, containing weakened forms of measles virus, mumps virus, and rubella virus.Read more...
MMR II Rubella Vaccine
M-M-R II is also known as Measles, Mumps, and Rubella Virus Vaccine Live, is a live virus vaccine, containing weakened forms of measles virus, mumps virus, and rubella virus.Read more...
Mosquirix Malaria Vaccine
Mosquirix (RTS,S/AS01) is a recombinant vaccine candidate consisting of the P. falciparum circumsporozoite protein (CSP) from the pre-erythrocytic stage.Read more...
mRNA-1647 Cytomegalovirus Vaccine
mRNA-1647 is a vaccine candidate combining six mRNAs in a single vial, which encode for two antigens on the surface of cytomegalovirus (CMV): five mRNAs encoding the subunits that form the membrane-bound pentamer complex and one mRNA encoding the full-length membrane-bound glycoprotein B (gB).Read more...
mRNA-1653 hMPV+PIV3 Vaccine
mRNA-1653 is a combination vaccine that consists of two distinct mRNA sequences encoding the fusion (F) proteins of hMPV and PIV3 formulated in Moderna’s proprietary lipid nanoparticle (LNP) technology.Read more...
mRNA-1893 Zika Vaccine
mRNA-1893 contains an mRNA sequence encoding for the structural proteins of the Zika virus and is designed to cause cells to secrete virus-like particles, mimicking the response of the cell after natural infection.Read more...
mRNA-1944 Chikungunya Vaccine
mRNA-1944 encodes a fully human IgG antibody originally isolated from B cells of a patient with a prior history of potent immunity against Chikungunya infection.Read more...
mRNA-4157 Cancer Vaccine
mRNA-4157 is a therapeutic vaccine candidate that is a combination of validated defined neoantigens, predicted neoepitopes and mutations in driver genes into a single mRNA concatemer (mRNA-4650).Read more...
Multimeric-001 Influenza Vaccine
Multimeric-001 (M-001) is a recombinant protein containing 9 conserved epitopes from Influenza A and B that are common to the vast majority of influenza viruses.Read more...
MV-CHIK Chikungunya Vaccine
MV-CHIK is a vaccine candidate utilizing Themis’ measles vector platform. MV-CHIK consists of a recombinant live Schwarz-strain measles-vectored vaccine expressing chikungunya virus structural proteins.Read more...
MV-LASV Lassa Fever Vaccine
MV-LASV vaccine candidate is a recombinant, live-attenuated, viral vectored vaccine, based on the backbone of the measles Schwarz virus strain for prophylaxis of Lassa infectionRead more...
MVA-M1+NP Influenza A Vaccine
MVA-M1+NP vaccine candidate consists of MVA, a replication-deficient pox viral vector that has been safely tested in thousands of patients, to generate a strong immune reaction against Matrix 1 (M1) and Nucleoprotein (NP) influenza antigens. Read more...
MVX-ONCO-1 Cancer Immunotherapy Vaccine
MVX-ONCO-1 is an anti-cancer therapy based upon triggering the patient's own natural immune responseRead more...
NanoFlu Influenza Vaccine
NanoFlu is an influenza vaccine candidate which is a recombinant hemagglutinin (HA) protein nanoparticle influenza vaccine produced in an Sf9 insect cell-baculovirus system.Read more...
NanoVax Herpes Simplex Virus Vaccine
NanoVax is an adjuvant platform used in the development of a vaccine candidate that will provide protection against the two viruses that can cause genital herpes. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.Read more...
NEO-PV-01 Cancer Vaccine
NEO-PV-01 Cancer vaccine candidate is a personal neoantigen vaccine which is custom designed and manufactured for each individual patient.Read more...
NeoVax Cancer Vaccine
NeoVax is a personalized experimental vaccine designed to recognize cancer-specific proteins, called neoantigens, that are present on the individual’s cancer cells but not on normal cells.Read more...
Nexvax2 - Celiac Disease Vaccine
Nexvax2 is a combination of three proprietary peptides that elicit an immune response in patients with celiac disease (CeD) who carry the immune recognition gene, HLA-DQ2.5, which accounts for the condition in 80% to 90% of patients.Read more...
Niprab Nipah Virus Vaccine
Niprab, a pre-clinical vaccine candidate, is a novel recombinant vaccine that uses a modified rabies virus vector and incorporates a gene from Nipah virus Read more...
NOUS-209 Cancer Vaccine
NOUS-209 is an off-the-shelf therapeutic vaccine based on shared tumor neoantigens.Read more...
OVX836 Universal Influenza Vaccine
OVX836 is a Universal Influenza Vaccine candidate which targets the NucleoProtein (NP), a highly conserved internal antigen, much less prone to mutations than the traditional surface antigens targeted by current flu vaccines, thus alleviating the need for annual updatesRead more...
Pamvac Malaria Vaccine
Pamvac is a vaccine candidate based on a recombinant fragment of VAR2CSA, the Plasmodium falciparum protein responsible for binding to the placenta via chondroitin sulfate A (CSA).Read more...
Pediarix Diphtheria Vaccine
Pediarix contains noninfectious proteins from diphtheria, tetanus, and pertussis bacteria, hepatitis B virus, and inactivated polioviruses.Read more...
Pediarix Pertussis Vaccine
Pediarix contains noninfectious proteins from diphtheria, tetanus, and pertussis bacteria, hepatitis B virus, and inactivated polioviruses.Read more...
Pediarix Polio Vaccine
Pediarix contains noninfectious proteins from diphtheria, tetanus, and pertussis bacteria, hepatitis B virus, and inactivated polioviruses.Read more...
Pediarix Tetanus Vaccine
Pediarix contains noninfectious proteins from diphtheria, tetanus, and pertussis bacteria, hepatitis B virus, and inactivated polioviruses.Read more...
Pediarix Hepatitis B Vaccine
Pediarix contains noninfectious proteins from diphtheria, tetanus, and pertussis bacteria, hepatitis B virus, and inactivated polioviruses.Read more...
PedvaxHIB Haemophilus influenzae type b Vaccine
PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age.Read more...
PennVax-GP HIV Vaccine
PennVax-GP has been optimized to target two env antigens, as well as gag and pol antigens. This comprehensive targeting gives PennVax-GP the potential to provide global coverage against HIV-1 subtypesRead more...
Pentacel Diphtheria Vaccine
Pentacel vaccine consists of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component Read more...
Pentacel HIB Vaccine
Pentacel vaccine consists of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component Read more...
Pentacel Pertussis Vaccine
Pentacel vaccine consists of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component Read more...
Pentacel Polio Vaccine
Pentacel vaccine consists of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component Read more...
Pentacel Tetanus Vaccine
Pentacel vaccine consists of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component Read more...
PF-04965842 Atopic Dermatitis Vaccine
PF-04965842 is an oral small molecule vaccine candidate that selectively inhibits Janus kinase (JAK) 1.Read more...
PF-06482077 20-Valent Pneumococcal Vaccine
PF-06482077 is a 20-Valent pneumococcal conjugate vaccine candidate to help protect adults from a substantial invasive pneumococcal disease and pneumonia burdenRead more...
PolyPEPI1018 an investigational off-the-shelf vaccine for colorectal cancer induced promising immune responses and clinical signs of efficacy when given in combination with standard maintenance therapy in metastatic colorectal cancer... Read more...
Prevnar 13 Pneumococcal Vaccine
Prevnar 13 is a sterile suspension of saccharides of the capsular antigens of Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F, individually linked to non-toxic diphtheria CRM197 protein. Read more...
Priorix MMR Measles Vaccine
Priorix is a lyophilized mixed preparation of the attenuated Schwarz measles, RIT 4385 mumps (derived from Jeryl Lynn strain) and Wistar RA 27/3 rubella strains of viruses.Read more...
Priorix MMR Mumps Vaccine
Priorix is a lyophilized mixed preparation of the attenuated Schwarz measles, RIT 4385 mumps (derived from Jeryl Lynn strain) and Wistar RA 27/3 rubella strains of viruses.Read more...
Priorix MMR Rubella Vaccine
Priorix is a lyophilized mixed preparation of the attenuated Schwarz measles, RIT 4385 mumps (derived from Jeryl Lynn strain) and Wistar RA 27/3 rubella strains of viruses.Read more...
Proquad MMR plus Varicella Vaccine
ProQuad (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) is a combined, attenuated, live virus vaccine containing measles, mumps, rubella, and varicella viruses.Read more...
ProscaVax Prostate Cancer Vaccine
ProscaVax vaccine incorporates scientifically proven and clinically validated treatments for cancer.Read more...
Provenge Prostate Cancer Vaccine
Provenge active components are autologous antigen-presenting cells (APCs) and the protein called PAP-GM-CSF.
APCs are activated during a defined culture period with a recombinant human protein, PAP-GM-CSF, consisting of prostatic acid phosphatase (PAP), an antigen expressed in prostate cancer tissue, linked to granulocyte-macrophage colony-stimulating factor (GM‑CSF), an immune cell activator.Read more...
PRV-101 Type 1 Diabetes Vaccine
PRV-101 is a polyvalent coxsackievirus B (CVB) vaccine licensed from Vactech, Ltd., which Provention is developing as a potential vaccine for acute coxsackie infection and for the potential prevention of up to 50% of worldwide type 1 diabetes (T1D) cases.Read more...
PRV-3279 Lupus Vaccine
PRV-3279 is a humanized diabody (a bispecific scaffold biologic molecule) targeting the B-cell surface proteins, CD32B and CD79B, which has the potential to intercept the pathophysiology of systemic lupus erythematosus (SLE) and other B cell-mediated autoimmune diseases.Read more...
Quadracel Diphtheria Vaccine
Quadracel vaccine contains diphtheria toxoid, tetanus toxoid, acellular pertussis [pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), fimbriae types 2 and 3 (FIM)], inactivated poliomyelitis vaccine (IPV) type 1 (Mahoney), type 2 (MEF-1) and type 3 (Saukett)].Read more...
Quadracel Pertussis Vaccine
Quadracel vaccine contains diphtheria toxoid, tetanus toxoid, acellular pertussis [pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), fimbriae types 2 and 3 (FIM)], inactivated poliomyelitis vaccine (IPV) type 1 (Mahoney), type 2 (MEF-1) and type 3 (Saukett)].Read more...
Quadracel Polio Vaccine
Quadracel vaccine contains diphtheria toxoid, tetanus toxoid, acellular pertussis [pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), fimbriae types 2 and 3 (FIM)], inactivated poliomyelitis vaccine (IPV) type 1 (Mahoney), type 2 (MEF-1) and type 3 (Saukett)].Read more...
Quadracel Tetanus Vaccine
Quadracel vaccine contains diphtheria toxoid, tetanus toxoid, acellular pertussis [pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), fimbriae types 2 and 3 (FIM)], inactivated poliomyelitis vaccine (IPV) type 1 (Mahoney), type 2 (MEF-1) and type 3 (Saukett)].Read more...
RabAvert Rabies Vaccine
RabAvert is a vaccine that contains an inactivated rabies antigen.Read more...
Recombivax HB Hepatitis B Vaccine
Recombivax HB consists of each 1 mL contains 10 µg hepatitis B surface antigenRead more...
Redeeflu Influenza Vaccine
Redeeflu is a nasal vaccine candidate utilizing a proprietary M2 deleted, single replication (M2SR) influenza virus.Read more...
ResVax RSV Vaccine
ResVax is a vaccine candidate composed of recombinant RSV F nanoparticles adsorbed to aluminum phosphate. The F protein is essential to RSV infectivity and is the target of palivizumab.Read more...
RH5.1/AS01 Malaria Vaccine
RH5.1/AS01 is a vaccine candidate that make many different types of antibodies against the same RH5 protein target.
The malaria parasite's protein, RH5, must bind to a human protein on... Read more...
RiVax Ricin Vaccine
RiVax is a safe alum-adjuvanted subunit vaccine candidate which may prevent death and injury from any route of exposure to ricin toxin.Read more...
Rotarix Rotavirus Vaccine
Rotarix is a live, attenuated rotavirus vaccine derived from the human 89-12 strain which belongs to G1P[8] typeRead more...
Rotateq Rotavirus Vaccine
RotaTeq is a live, oral pentavalent vaccine that contains 5 reassortant viruses.Read more...
RV144 HIV Vaccine
RV144 is an HIV vaccine candidate that combines two different vaccine types: a prime and a booster.Read more...
rVSVN4CT1-EBOVGP1 Ebola Vaccine
rVSVN4CT1-EBOVGP1 is a Monovalent Ebola Zaire Vaccine. Read more...
Sabin IPV Polio Vaccine
Sabin IPV is a liquid trivalent vaccine produced from Sabin poliovirus type 1, 2, and 3 strains grown on Vero cells. Read more...
Sci-B-Vac Hepatitis B Vaccine
Sci-B-Vac is a licensed, third-generation hepatitis B trivalent vaccine which mimics all three surface antigens, pre-S1, pre-S2, and S, of the hepatitis B virus (“HBV”).Read more...
SCIB1 Cancer Vaccine
SCIB1 is a cancer vaccine candidate that is being developed for the treatment of melanoma.Read more...
scMAYV-E Mayaro Virus Vaccine
scMAYV-E is a novel DNA vaccine that encodes a synthetically-designed consensus MAYV envelope sequence.Read more...
ShigETEC Diarrhea vaccine
ShigETEC vaccine candidate is based on a live, genetically attenuated Shigella vaccine strain able to induce broad protection against shigellosis.Read more...
Shingrix Shingles Vaccine
Shingrix is an adjuvanted recombinant zoster vaccine, consisting of the varicella-zoster virus glycoprotein E antigen and the AS01B adjuvant system, a proprietary adjuvant containing QS-21 and MPL with liposomes.Read more...
Sky Zoster Shingles Vaccine
Sky Zoster is a live-attenuated zoster vaccine developed and tested in Korea Read more...
Stamaril Yellow Fever Vaccine
Stamaril is a live, attenuated vaccine that contains the active substance Yellow fever virus1 17D-204 strain produced in specified pathogen-free chick embryos.Read more...
SurVaxM Cancer Vaccine
SurVaxM is a peptide mimic immunotherapeutic vaccine (immunotherapy) that targets survivin, a cell-survival protein present in 95 percent of glioblastomas and many other cancers.Read more...
TAK-003 Dengue Vaccine
TAK-003 is an investigational live-attenuated tetravalent dengue vaccine, preventing dengue fever caused by any of the four serotypes of the dengue virus. Read more...
TAK-214 Norovirus Vaccine
TAK-214 a vaccine candidate uses virus-like particle (VLP) antigens, which are proteins that precisely mimic the outer surface of norovirus. The vaccine includes antigens from genotypes GI.1 and GII.4, to represent both of the genogroups that cause the majority of human illness.Read more...
TAK-426 Zika Vaccine
TAK-426 (PIZV) is a purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.Read more...
TetraVax-DV-TV003 Dengue Vaccine
TetraVax-DV-TV003 is a live attenuated recombinant tetravalent dengue vaccine.Read more...
TG4001 HPV Cancers
TG4001, previously known as Tipapkinogen Sovacivec, is a vaccine candidate using an attenuated and modified poxvirus (MVA) as a vector expressing the HPV16 E6 and E7 proteins (rendered non-oncogenic) and interleukin-2. Read more...
TG4050 Ovarian Cancer Therapeutic Vaccine
TG4050 is an individualized MVA-based immunotherapy designed to stimulate and educate the immune system of patients to recognize and destroy tumor cells. Read more...
TLPLDC Melanoma Vaccine
TLPLDC is an autologous therapeutic cancer vaccine that is made from a patient’s own cells and is designed to stimulate the immune system to recognize tumor cells and fight the patient's specific (or unique) cancer.Read more...
TMCP2 Gonorrhea Vaccine
TMCP2 is a vaccine candidate to treat Gonorrhea. It is a complex peptide that is both scalable and economically produced to a high degree of purity.Read more...
Trumenba Meningitis B Vaccine
Trumenba is a sterile suspension composed of two recombinant lipidated factor H binding protein (fHBP) variants from N. meningitidis serogroup B, one from fHBP subfamily A and one from subfamily B (A05 and B01, respectively).Read more...
Twinrix Hepatitis A Vaccine
Twinrix is a bivalent vaccine containing the antigenic components used in producing HAVRIX (strain HM175) and ENGERIX-B [noninfectious hepatitis B virus surface antigen (HBsAg).].Read more...
Twinrix Hepatitis B Vacccine
Twinrix is a bivalent vaccine containing the antigenic components used in producing HAVRIX (strain HM175) and ENGERIX-B [noninfectious hepatitis B virus surface antigen (HBsAg).].Read more...
TY014 Yellow Fever Therapeutic Vaccine
TY014 will be the first therapeutic in the world, specifically targeting Yellow Fever Virus (YFV), to enter clinical trials. It is anticipated that a monoclonal antibody therapeutic could be administered to infected cases to reduce disease severity within the patient and their contacts.Read more...
Typbar TCV Typhoid Vaccine
Typbar TCV is a Typhoid Vi capsular polysaccharide-tetanus toxoid conjugate vaccine. Read more...
Typhim VI Typhoid Vaccine
Typhim VI is a sterile solution, prepared from the purified polysaccharide capsule of Salmonella typhi (Ty 2 strain).Read more...
UB-311 Alzheimer's Vaccine
UB-311 is fully synthetic and employs the UBITh platform technologies to target aggregated forms of beta-amyloid.Read more...
V114 Pneumococcal Disease Vaccine
V114 consists of pneumococcal polysaccharides from 15 serotypes conjugated to a CRM197 carrier protein and includes serotypes 22F and 33F, which are commonly associated with invasive pneumococcal disease (IPD) worldwide.Read more...
V180 Dengue Vaccine
V180 is inactivated, containing only the truncated form of the structural envelope protein, which prevents serotypes from interfering with each other.Read more...
Vaqta Hepatitis A Vaccine
Vaqta is an inactivated whole virus vaccine derived from hepatitis A virus grown in cell culture in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain.Read more...
Varivax Varicella Vaccine
Varivax is a live, attenuated varicella-zoster vaccine, a weakened form of the chickenpox virus.Read more...
Vaxchora Cholera Vaccine
Vaxchora is a live attenuated recombinant V. cholerae O1 Inaba Vaccine Strain CVD 103-HgR, which is able to synthesize the immunogenic nontoxic B subunit of CT (encoded by the ctxB gene).Read more...
Vaxelis Diphtheria Vaccine
Vaxelis is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...
Vaxelis H. influenzae type b Vaccine
Vaxelis is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...
Vaxelis Hepatitis B Vaccine
Vaxelis is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from Merck.Read more...
Vaxelis Pertussis Vaccine
Vaxelis is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...
Vaxelis Polio Vaccine
Vaxelis is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...
Vaxelis Tetanus Vaccine
Vaxelis is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...
VBI-1501 Cytomegalovirus (CMV) Vaccine
VBI-1501 is a vaccine candidate containing a gB antigen which is a major antigen for the induction of neutralizing antibodies against CMV.Read more...
VBI-1901 Glioblastoma (GBM) Cancer Vaccine
VBI-1901 is a polyvalent therapeutic vaccine candidate designed to direct an immune response against gB and pp65, two CMV antigens that are highly immunogenic targets during natural infection. Read more...
VBI-2601 Hepatitis B Vaccine
VBI-2601 is a therapeutic vaccine candidate that targets B- and T-cell immunity through several key mechanisms of actionRead more...
VCL-HB01 Genital Herpes (HSV2) Vaccine
VCL-HB01 is a therapeutic HSV plasmid DNA vaccine candidate formulated with Vaxfectin.Read more...
VGX-3100 HPV Cancer Vaccine
VGX-3100 is an investigational immunotherapy vaccine which includes DNA plasmids targeting the E6 and E7 proteins of HPV types 16 and 18.Read more...
Vivotif Typhoid Vaccine
Vivotif Oral contains live bacteria called Salmonella typhi strain Ty21a, which do not cause typhoid fever.Read more...
VLA15 Lyme Disease Vaccine
VLA15 is a multivalent Lyme Disease vaccine candidate that targets the outer surface protein A (OspA) of Borrelia. It is designed for prophylactic, active immunization against Lyme disease aiming for protection against the majority of human pathogenic Borrelia species.
VLA1553 is a monovalent, single dose, live-attenuated vaccine candidate.Read more...
VLA1601 Zika Vaccine
VLA1601 is a purified, inactivated, whole Zika virus (ZIKV) vaccine candidate adsorbed on aluminum hydroxide (alum).Read more...
VPM1002 Tuberculosis Vaccone
VPM1002 is a genetically modified BCG vaccine derived from the Mycobacterium bovis BCG subtype Prague characterized as rBCGÄureC::Hly+. Read more...
VRC-ZKADNA090-00-VP Zika Virus Vaccine
VRC-ZKADNA090-00-VP is a Zika virus wildtype DNA vaccine candidate.Read more...
VRC5283 Zika Virus Vaccine
VRC5283 is a Zika Virus DNA Vaccine candidate. It is composed of a single closed-circular DNA plasmid that encodes with wild type precursor transmembrane M and envelope proteins from the H/PF/2013 strain of ZIKV.Read more...
VXA‑G1.1-NN Norovirus Vaccine
VXA-G1.1-NN is an Oral Vaccine Candidate Tablet addressing Norovirus.Read more...
VXN-319 crKP Vaccine
VXN-319 is a semi-synthetic conjugate early-stage vaccine candidate. Read more...
YF-VAX Yellow Fever Vaccine
YF-VAX is prepared by culturing the 17D-204 strain of yellow fever virus in living avian leukosis virus-free (ALV-free) chicken embryos. The vaccine contains sorbitol and gelatin as a stabilizer, is lyophilized, and is hermetically sealed under nitrogen.Read more...
Zika Vaccines
Mosquito-borne Zika has been around for decades, but there are no approved Zika virus vaccines available in the USA today.Read more...
Zostavax Shingles Vaccine
Zostavax is a live, attenuated varicella-zoster virus.Read more...
ZPIV Zika Vaccine
ZPIV is a Zika virus vaccine candidate which consists of a purified formalin-inactivated Zika virus.Read more...
